Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 7 June 2018, 11:00 HKT/SGT
Share:
    

Source: SCIEX
SCIEX Announces Latest Innovations for Improving Healthcare and Well-being at ASMS
Improving the accuracy and user-friendliness of mass spec technologies to enable critical decisions in safety, healthcare and nutrition

SINGAPORE, June 7, 2018 - (Media OutReach) - SCIEX, a global leader in life science analytical technologies, has announced today that it will highlight a suite of recent innovations for streamlining biotherapeutics research and development, as well as its latest technologies for delivering accessible, high performance clinical diagnostics, at ASMS 2018. These developments have been optimized for maximal sensitivity, accuracy and efficiency for scientists using challenging workflows in critical fields, without sacrificing robustness or ease of use.

Recent additions to the SCIEX biopharma portfolio:

- OptiFlow(TM) Quant Solution, which delivers highly sensitive micro flow quantitation for peptides. This solution includes the OptiFlow(TM) Turbo V Source with M5 MicroLC to deliver micro flow sensitivity at analytical flow usability, with flexible and user-friendly sample handling.

- Multiple Attribute Methodology (MAM) Workflow for simple yet in-depth LC-MS characterization and development of biologics, supported through the newly released SCIEX BioPharmaView(TM) 3.0 software. The MAM Workflow provides more complete analysis of the product quality profile while minimizing the burden of product quality attribute (PQA) monitoring and product purity testing.

New OS software:

- SCIEX is launching its SCIEX OS 1.4 software at ASMS, bringing the full package for quantitative and qualitative analysis to the majority of SCIEX instruments. The new operating system also offers complete 21 CFR Part 11 compliance for labs in regulated fields.

- This launch follows the MPX(TM) 2.0 software, which was recently developed for multiplexing LC separations within a single MS system, saving valuable laboratory time while improving flexibility.

Earlier this year, SCIEX also announced several other new technologies. These include the Citrine(TM) MS/MS System for clinical diagnostics, delivering highly sensitive and rapid quantification of large panels of molecules, as well as the OptiFlow Interface and C100HT Biologics Analyzer.

"These latest developments reflect the SCIEX commitment to improving the future of science and, ultimately, well-being," said Inese Lowenstein, President, SCIEX. "By making mass spec more sensitive, robust and user-friendly, we're enabling analysts and clinicians to make critical decisions with enhanced accuracy, while improving their lab productivity and reducing costs."

SCIEX will showcase its pioneering technologies throughout ASMS at booth #601 and at the SCIEX Hospitality and Demo Suite, at the Hilton Bayfront. In addition, scientists from SCIEX will provide a series of Users Meetings and Breakfast Seminars, as well as present numerous talks and posters during the ASMS Technical Program. For more information, please visit sciex.com/events/ASMS2018.

About SCIEX
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.

With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciex.com.

SCIEX social: Twitter: @SCIEXnews, LinkedIn (https://ter.li/pt7njb) and Facebook (https://ter.li/au1hae).

For Research Use Only. Not for use in diagnostic procedures. RUO-MKT-12-7957-A

AB Sciex is operating as SCIEX.

(c)2018 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex(TM) is being used under license.

Contact Information
Sean Iverson
Marketing Director
Sean.Iverson@sciex.com
508-383-7146

Editorial follow-up
EASTWEST PR for SCIEX
Jim James | Josiah Tan
Tel: (65) 6222 0306
Email: sciex@eastwestpr.com


June 7, 2018 11:00 HKT/SGT
Topic: Press release summary

http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Outcrop Gold Provides Corporate Update  
Apr 22, 2019 23:00 HKT/SGT
Network International and JCB enable JCB Contactless acceptance in UAE  
Apr 22, 2019 16:00 HKT/SGT
Mitsubishi Shipbuilding Holds Christening Ceremony for Next-Generation LNG Carrier "Diamond Gas Sakura"  
Apr 22, 2019 14:10 HKT/SGT
Network International and JCB enable JCB Contactless acceptance in the United Arab Emirates  
Apr 22, 2019 14:00 HKT/SGT
Toyota Establishes Joint Research Institute with China's Tsinghua University  
Apr 22, 2019 10:20 HKT/SGT
Fujitsu to Introduce Sustainable Ingredients to Employee Cafeterias on Ongoing Basis  
Apr 22, 2019 10:08 HKT/SGT
Hemp, Inc. Releases 2018 Annual Report Showing Substantial Revenue Increase Over Previous Year  
Apr 22, 2019 09:00 HKT/SGT
HKTDC Hong Kong Houseware Fair and Home Textiles Fair open today  
Apr 20, 2019 19:00 HKT/SGT
TOYOTA GAZOO Racing Eyes South American Gravel Glory  
Apr 19, 2019 16:30 HKT/SGT
Toyota, DENSO and SoftBank Vision Fund to Invest $1 Billion in Uber's Advanced Technologies Group  
Apr 19, 2019 08:35 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6721 7212

Connect With us: